Drug GMP Investor Alerts in Brief
This article was originally published in The Gold Sheet
Executive Summary
Pharmaceutical manufacturers alerted investors to manufacturing quality issues that arose in the quarter ending June 30, including: Actavis, Acorda, Perrigo, Impax, Cubist, Aastrom and Amphastar.